These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34342996)

  • 1. Discovery of 3,5-Dimethyl-4-Sulfonyl-1
    Zhu PJ; Yu ZZ; Lv YF; Zhao JL; Tong YY; You QD; Jiang ZY
    J Med Chem; 2021 Aug; 64(15):11330-11353. PubMed ID: 34342996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 1-(5-(1H-benzo[d]imidazole-2-yl)-2,4-dimethyl-1H-pyrrol-3-yl)ethan-1-one derivatives as novel and potent bromodomain and extra-terminal (BET) inhibitors with anticancer efficacy.
    Kong B; Zhu Z; Li H; Hong Q; Wang C; Ma Y; Zheng W; Jiang F; Zhang Z; Ran T; Bian Y; Yang N; Lu T; Zhu J; Tang W; Chen Y
    Eur J Med Chem; 2022 Jan; 227():113953. PubMed ID: 34731760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors.
    Wan Y; Li Y; Yan C; Wen J; Tang Z
    Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Optimization of 3-Phenyl-
    Li Y; Fan W; Gong Q; Tian J; Zhou M; Li Q; Uwituze LB; Zhang Z; Hong R; Wang R
    J Med Chem; 2021 Jul; 64(14):10260-10285. PubMed ID: 34228434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
    Liu L; Liu R; Yang X; Hou X; Fang H
    Eur J Med Chem; 2020 Apr; 191():112142. PubMed ID: 32088497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and development of thiazolidine-2,4-dione derivatives as Bcl-2/Mcl-1 dual inhibitors.
    Long J; Chen H; Yan Z; Zhou L; Deng R; Wang J; Tang Z; Wan Y
    Bioorg Chem; 2024 Oct; 151():107687. PubMed ID: 39096559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
    Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
    Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.
    Lee T; Christov PP; Shaw S; Tarr JC; Zhao B; Veerasamy N; Jeon KO; Mills JJ; Bian Z; Sensintaffar JL; Arnold AL; Fogarty SA; Perry E; Ramsey HE; Cook RS; Hollingshead M; Davis Millin M; Lee KM; Koss B; Budhraja A; Opferman JT; Kim K; Arteaga CL; Moore WJ; Olejniczak ET; Savona MR; Fesik SW
    J Med Chem; 2019 Apr; 62(8):3971-3988. PubMed ID: 30929420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL-1.
    Daressy F; Malard F; Seguy L; Guérineau V; Apel C; Dumontet V; Robert A; Groo AC; Litaudon M; Bignon J; Desrat S; Malzert-Fréon A; Wiels J; Lescop E; Roussi F
    ChemMedChem; 2021 Jun; 16(11):1788-1797. PubMed ID: 33665938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells.
    Doi K; Gowda K; Liu Q; Lin JM; Sung SS; Dower C; Claxton D; Loughran TP; Amin S; Wang HG
    Cancer Biol Ther; 2014; 15(12):1688-99. PubMed ID: 25535900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors.
    Lee T; Bian Z; Zhao B; Hogdal LJ; Sensintaffar JL; Goodwin CM; Belmar J; Shaw S; Tarr JC; Veerasamy N; Matulis SM; Koss B; Fischer MA; Arnold AL; Camper DV; Browning CF; Rossanese OW; Budhraja A; Opferman J; Boise LH; Savona MR; Letai A; Olejniczak ET; Fesik SW
    FEBS Lett; 2017 Jan; 591(1):240-251. PubMed ID: 27878989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1
    Deng H; Zhang J; Liu L; Zhang H; Han Y; Wu L; Jing Y; Huang M; Zhao L
    J Med Chem; 2024 Aug; 67(16):13925-13958. PubMed ID: 39121336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors.
    Du J; Liu L; Liu B; Yang J; Hou X; Yu J; Fang H
    Future Med Chem; 2020 Jul; 12(14):1293-1304. PubMed ID: 32397829
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
    Brasca MG; Nesi M; Avanzi N; Ballinari D; Bandiera T; Bertrand J; Bindi S; Canevari G; Carenzi D; Casero D; Ceriani L; Ciomei M; Cirla A; Colombo M; Cribioli S; Cristiani C; Della Vedova F; Fachin G; Fasolini M; Felder ER; Galvani A; Isacchi A; Mirizzi D; Motto I; Panzeri A; Pesenti E; Vianello P; Gnocchi P; Donati D
    Bioorg Med Chem; 2014 Sep; 22(17):4998-5012. PubMed ID: 25009002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.
    Pettus LH; Andrews KL; Booker SK; Chen J; Cee VJ; Chavez F; Chen Y; Eastwood H; Guerrero N; Herberich B; Hickman D; Lanman BA; Laszlo J; Lee MR; Lipford JR; Mattson B; Mohr C; Nguyen Y; Norman MH; Powers D; Reed AB; Rex K; Sastri C; Tamayo N; Wang P; Winston JT; Wu B; Wu T; Wurz RP; Xu Y; Zhou Y; Tasker AS; Wang HL
    J Med Chem; 2016 Jul; 59(13):6407-30. PubMed ID: 27285051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.
    Rescourio G; Gonzalez AZ; Jabri S; Belmontes B; Moody G; Whittington D; Huang X; Caenepeel S; Cardozo M; Cheng AC; Chow D; Dou H; Jones A; Kelly RC; Li Y; Lizarzaburu M; Lo MC; Mallari R; Meleza C; Rew Y; Simonovich S; Sun D; Turcotte S; Yan X; Wong SG; Yanez E; Zancanella M; Houze J; Medina JC; Hughes PE; Brown SP
    J Med Chem; 2019 Nov; 62(22):10258-10271. PubMed ID: 31736296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.
    Wan Y; Dai N; Tang Z; Fang H
    Eur J Med Chem; 2018 Feb; 146():471-482. PubMed ID: 29407973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent
    Tarr JC; Salovich JM; Aichinger M; Jeon K; Veerasamy N; Sensintaffar JL; Arnhof H; Samwer M; Christov PP; Kim K; Wunberg T; Schweifer N; Trapani F; Arnold A; Martin F; Zhao B; Miriyala N; Sgubin D; Fogarty S; Moore WJ; Stott GM; Olejniczak ET; Engelhardt H; Rudolph D; Lee T; McConnell DB; Fesik SW
    J Med Chem; 2024 Aug; 67(16):14370-14393. PubMed ID: 39102508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.